All posts by: Michael Zand

About Michael Zand

China will grant CRISPR patent to UC – Daily Californian

Continue reading

2017-06-21 NEWS

Daily Californian

China will grant CRISPR patent to UC
Daily Californian
China’s State Intellectual Property Office, or SIPO, announced Monday that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology. China’s
Intellia to win China patent for CRISPRBSI bureau (press release)

all 2 news articles »

Continue reading

2017-06-21 NEWS

Drug Discovery & Development

Cell Medica Acquires WT1 Cancer Immunotherapy from CGT Catapult
Drug Discovery & Development
Cell Medica announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and the initiation of a collaboration to establish cell therapy manufacturing for Cell Medica at CGT Catapult’s GMP …

Continue reading

2017-06-21 NEWS

Financial Express

How LifeCell became the most accredited stem cell bank in India
Financial Express
Chennai-based LifeCell, the provider of preventive healthcare services for family wellness, is the world’s second-largest provider of umbilical cord stem cells. Founded in 2004, the company has technological collaboration with the US-based Cryo-Cell …

Continue reading

2017-06-20 NEWS

The News Herald

Gulf Coast State College looks to incorporate CRISPR into labs …
The News Herald
If DNA were an essay and genes individual words, CRISPR would be the keyboard: adding, deleting and editing to create, for instance, drought-resistant crops.
CRISPR Pioneer Doudna: Humans on Cusp of ‘New Age in … – KQEDKQED

all 7 news articles »